Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia
Conditions
Androgenetic Alopecia · Female Pattern Baldness
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Fachklinik Bad Bentheim Klinisches Studienzentrum, Bad Bentheim, Germany
CRC - Charité Universitätsmedizin Berlin Clinical Research Center for Hair and Skin Science, Berlin, Germany
emovis by Futuremeds GmbH, Berlin, Germany
Contact: Study coordinator (Thomas Lienhard) · thomas.lienhard@futuremeds.com · +49 (0)30 439 741 223Rosenpark Reasearch GmbH, Darmstadt, Germany
Contact: Study coordinator (Karolina Kievisaite) · karolina.kievisaite@rosenparkresearch.de · +49 (0)6151627070Privatpraxis Dr. Hilton & Partner, Düsseldorf, Germany
Klinik für Dermatologie, Venerologie und Allergologie - Universitätsmedizin Frankfurt, Frankfurt, Germany
Dermaticum -Dr. med. Mario Bittar und Kollegen, Freiburg im Breisgau, Germany
Eurofins bioskin - Research Center Dermatology, Hamburg, Germany
Klinische Forschung Karlsruhe GmbH, Karlsruhe, Germany
Siteworks - Prüfzentrum Lohne, Löhne, Germany
Zentrale Studienkoordination für innovative Dermatologie (ZiD) Klinik für Hautkrankheiten Universitätsklinikum Münster (UKM), Münster, Germany
Haut-und Lasercentrum - Dr. Tanja Fischer und Kollegen, Potsdam, Germany
TRIDERM Study Site Dermatological practice Dr. Leitz and colleagues, Stuttgart, Germany
Study leads
Ana López-Ballesteros
Study Director
Industrial Farmacéutica Cantabria, S.A.